Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.
about
Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastasesCritical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastasesIntegrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma.BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis.Factors affecting surgical margin recurrence after hepatectomy for colorectal liver metastasesT1 colorectal cancer with synchronous liver metastasis.Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).Colorectal cancer liver metastasis trends in the kingdom of Saudi ArabiaExtended pathology reporting of resection specimens of colorectal liver metastases: the significance of a tumour pseudocapsule.Impact of peri-operative bevacizumab on survival in patients with resected colorectal liver metastases: an analysis of the LiverMetSurvey.Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signaling.Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases.CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.Histopathological evaluation of resected colorectal cancer liver metastases: what should be done?Circulating Tumor Cells In Colorectal Cancer.MOLECULAR PATHWAYS: TARGETING THE MICROENVIRONMENT OF LIVER METASTASES.Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial?Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases.Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling.TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration.Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.Extramural vascular invasion detected by contrast-enhanced multiple-row detectors computed tomography (ceMDCT) as a predictor of synchronous metastases in colon cancer.Overexpression of epithelial cell transforming 2 protein in colorectal carcinoma predicts a poor prognosis.The impact of advanced age on short-term outcomes following gastric cancer resection: an ACS-NSQIP analysis.Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol.Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.
P2860
Q34003713-3B9BDB64-01B8-4C7C-BCCF-8A57B7549421Q34156811-25D7A420-BA08-4736-9A19-F18CDA6D6EC1Q34780974-23B1371D-7AE6-4FFF-A5CE-2415318E27B8Q36086837-99770E1C-5D0D-49C4-86A1-F3061EA50C62Q36391787-0C121F4D-0A8A-4A24-B6F2-1E181DEBB0B6Q36945965-C8C65D72-3526-45BC-86BC-86EFE8B8E39EQ37046848-D42ECC42-FF27-4579-9F6D-A06BC66A03ADQ37308725-16E1BD7C-E39A-490B-AC32-3461D06C4789Q37311883-4A7D0F2C-6427-4C20-A24D-A5015352E571Q37628445-FD35E975-73AF-46C6-997A-D80DA285F51FQ37669073-FC2F88D1-39F5-4D24-B84B-53ABF1BB2E0DQ37697146-BEC212C7-C74F-476B-8269-DA0902F4DB47Q37708019-183E62E1-EACA-4204-863E-4C2228F95583Q37718372-E46D6704-E672-463F-8955-1D9436A3FCD8Q38114156-C99D75C7-FAAC-4602-B867-1CAB634FA45CQ38546739-569D399E-F25F-4F0C-96A3-FF51655AC8F7Q38671001-09575202-BDE4-4DE1-992C-F93D6DFA5083Q38813248-9F4B0C87-9D74-4E89-AF9A-4B0EE1672FA6Q41265675-1621CF8B-D4E0-4C3A-B7FB-EE88635E7941Q42334837-11600E98-B44E-49A4-B71F-E270457C0B2AQ42404774-FB215194-EB49-45C1-8FDE-020B57B6AE16Q47106593-040BC944-9E1E-4E71-A901-98123EE62A63Q47150395-B70100A7-29CF-4052-9554-FF356578A15FQ47163564-D107DB19-CB1B-403F-BEBA-5FA98BE06E15Q47326034-154E5D64-699E-47CC-B6B9-AA3C5302B53EQ48146966-72951032-1C17-48EB-8EC0-D3B25319545CQ50703508-E46A17BC-E3D3-4BF0-82AA-BE968FA7CF80
P2860
Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinicopathological analysis o ...... r colorectal liver metastasis.
@ast
Clinicopathological analysis o ...... r colorectal liver metastasis.
@en
type
label
Clinicopathological analysis o ...... r colorectal liver metastasis.
@ast
Clinicopathological analysis o ...... r colorectal liver metastasis.
@en
prefLabel
Clinicopathological analysis o ...... r colorectal liver metastasis.
@ast
Clinicopathological analysis o ...... r colorectal liver metastasis.
@en
P2093
P2860
P356
P1433
P1476
Clinicopathological analysis o ...... r colorectal liver metastasis.
@en
P2093
Atsushi Takeshita
Fumitoshi Hirokawa
Junji Okuda
Koji Komeda
Michihiro Hayashi
Mitsuhiro Asakuma
Nobuhiko Tanigawa
Tetsunosuke Shimizu
Yoshiharu Miyamoto
Yoshihiro Inoue
P2860
P2888
P356
10.1186/1471-2482-10-27
P577
2010-09-27T00:00:00Z
P5875
P6179
1046059452